Putting Safety and Quality First
Patients come to the Kimmel Cancer Center at Jefferson for the latest in cancer treatments. In addition to leading-edge care, we also pride in our focus on another critical component of patient care: safety and quality assurance.
When you’re dealing with a cancer diagnosis and treatments such as radiation therapy, it’s important to know you can on your health, and know that the technologies helping you beat cancer are meticulously handled to assure the best and safest treatments possible.
Dr. Hurwitz is a widely recognized leader in the fields of thermal medicine and genitourinary oncology who came to Jefferson from Harvard University affiliated Dana-Farber/Brigham and Women’s Cancer Center in Boston. He will also serve as director of Thermal Oncology.
“I’m delighted to be joining an institution that already has a very prominent profile in quality assurance, excellence and innovation,” said Dr. Hurwitz. “I’m stepping into this new position to help Jefferson reach the next level in terms of developing a formalized, comprehensive quality assurance program that encompasses all aspects of quality, including research, education, and patient care and safety.”
Upon completion of his residency at Johns Hopkins Hospital in 1997, Dr. Hurwitz joined the faculty of Harvard Medical School, which he served as an associate professor.
He has been the recipient of National Health Institutes grant support for development of applications of hyperthermia and thermal ablation for treatment of prostate cancer, and recently served as the principal investigator of an international multi-center phase III trial to assess the use of magnetic resonance guided focused ultrasound ablation for treatment of painful bone metastases.
“We’re pleased that Dr. Hurwitz has joined the Jefferson family,” said Adam Dicker, MD, PhD, chair of the Department of Radiation Oncology. “His superb reputation, skill set, and devotion to quality assurance and patient safety are the perfect addition to the Department, and we look forward to taking it to new heights—which will no doubt help make a difference for patients here in the Philadelphia region and beyond.”